Company Search:
Advanced Search
Sponsored Links
Bayer AG - ADR Company Snapshot
Bayer AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other companies in this sector in the United States: Pfizer Inc. (2016 sales of $52.82 billion of which 55% was Operating Segment-Global Innovative Phar), Roche Holding Aktiengesellschaft ($51.16 billion of which 77% was Pharmaceuticals), and Novartis AG ($49.39 billion of which 66% was Innovative Medicines).

Sales Analysis. Bayer AG reported sales of $51.62 billion for the year ending December of 2016. This represents a very small increase of 1.0% versus 2015, when the company's sales were $51.09 billion. Despite this increase, sales are still below the level achieved in 2014, when Bayer AG reported sales of $55.77 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, Bayer AG had sales of $51.05 billion. Sales of Reconciliations saw an increase that was more than double the company's growth rate: sales were up 50.1% in 2016, from $4.41 million to $6.62 million. Bayer AG also saw significant increases in sales in Pharmaceuticals and Biological Products (up 19.5% to $18.12 billion) . Not all segments of Bayer AG experienced an increase in sales in 2016: sales of Consumer Care fell 33.8% to $6.66 billion. Bayer AG also experienced decreases in sales in Cropscience (down 4.3% to $10.94 billion) and All Other Segments (down 4.9% to $1.15 billion) .
  Stock Performance Chart for Bayer AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 31.82
(Figures in U.S. Dollars)
1 Week -1.0%   13 Weeks 2.0%  
4 Weeks -8.7%   52 Weeks 16.6%  
Bayer AG - ADR Key Data:
  Ticker: BAYA Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 51,620,348,370
(Year Ending Jan 2017).
Employees: 115,200
  Currency: U.S. Dollars Market Cap: 105,266,321,219
  Fiscal Yr Ends: December Shares Outstanding: 3,307,791,232
  Share Type: Stammaktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.